Arcellx, Inc. (ACLX)
114.83
+0.03
(+0.03%)
USD |
NASDAQ |
Apr 10, 16:00
114.84
+0.01
(+0.01%)
After-Hours: 20:00
Arcellx EPS Diluted (Quarterly) : -1.003 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.742 |
| Eli Lilly & Co. | 7.024 |
| Merck & Co., Inc. | 1.191 |
| Bristol Myers Squibb Co. | 0.5326 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -58.11M |
| Revenue (Quarterly) | 1.654M |
| Total Expenses (Quarterly) | 59.77M |
| Enterprise Value | 6.317B |
| Gross Profit Margin (Quarterly) | 0.79% |
| Profit Margin (Quarterly) | -3.51K% |
| Earnings Yield | -3.53% |
| Normalized Earnings Yield | -3.531 |